HPRL Awarded Phase II Continuation Small Business Innovation Research (SBIR) Grant for the “Discovery and Development of Anti-Diabetic Drugs” in Type I and Type II Diabetes.
Therapeutic Discovery Tax Grants Awarded
HPRL Awarded Qualifying Therapeutic Discovery Tax Grants for two of its on-going research programs; “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia” and “Discovery and Development of Anti-Diabetic Drugs.”
2009 Lasker Award
Dr. Charles Sawyers shares the 2009 Lasker Award for his work elucidating the mechanism of drug-resistance in Chronic Myelogenous Leukemia (CML).
Awarded SBIR Phase I Grant
HPRL Awarded Phase I Small Business Innovation Research (SBIR) Grant for “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia (CML).”
Awarded SBIR Phase II Grant
HPRL Awarded Phase II Small Business Innovation Research (SBIR) Grant for the “Discovery and Development of Anti-Diabetic Drugs.”
JDRF Partners with HPRL
The Juvenile Diabetes Research Foundation (JDRF) Partners with HPRL for therapeutic discovery and development in the area of Type I Diabetes.
